OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Shengyuan Zhang, Akosua Adom Agyeman, Christoforos Hadjichrysanthou, et al.
CPT Pharmacometrics & Systems Pharmacology (2023) Vol. 12, Iss. 10, pp. 1450-1460
Open Access | Times Cited: 8
Showing 8 citing articles:
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19
Lindsay E. Clegg, Oleg Stepanov, Henning Schmidt, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 5
Open Access | Times Cited: 4
Lindsay E. Clegg, Oleg Stepanov, Henning Schmidt, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 5
Open Access | Times Cited: 4
A mathematical modeling of COVID-19 treatment strategies utilizing the Laplace Adomian decomposition method
Morufu Oyedunsi Olayiwola, Adedapo Ismaila Alaje, Akeem Olarewaju Yunus, et al.
Results in Control and Optimization (2024) Vol. 14, pp. 100384-100384
Open Access | Times Cited: 3
Morufu Oyedunsi Olayiwola, Adedapo Ismaila Alaje, Akeem Olarewaju Yunus, et al.
Results in Control and Optimization (2024) Vol. 14, pp. 100384-100384
Open Access | Times Cited: 3
Development of a SARS‐CoV‐2 viral dynamic model for patients with COVID‐19 based on the amount of viral RNA and viral titer
D T Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 8, pp. 1354-1365
Open Access | Times Cited: 2
D T Yamaguchi, Ryosuke Shimizu, Ryuji Kubota
CPT Pharmacometrics & Systems Pharmacology (2024) Vol. 13, Iss. 8, pp. 1354-1365
Open Access | Times Cited: 2
Virus-mediated cell fusion of SARS-CoV-2 variants
Ava Amidei, Hana M. Dobrovolny
Mathematical Biosciences (2024) Vol. 369, pp. 109144-109144
Closed Access | Times Cited: 1
Ava Amidei, Hana M. Dobrovolny
Mathematical Biosciences (2024) Vol. 369, pp. 109144-109144
Closed Access | Times Cited: 1
Modeling the transmission mitigation impact of testing for infectious diseases
Casey Middleton, Daniel B. Larremore
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Casey Middleton, Daniel B. Larremore
Science Advances (2024) Vol. 10, Iss. 24
Open Access | Times Cited: 1
Modeling the Transmission Mitigation Impact of Testing for Infectious Diseases
Casey Middleton, Daniel B. Larremore
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Casey Middleton, Daniel B. Larremore
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Vaccine and antiviral drug promise for preventing post-acute sequelae of COVID-19, and their combination for its treatment
Tomonari Sumi, Kouji Harada
Frontiers in Immunology (2024) Vol. 15
Open Access
Tomonari Sumi, Kouji Harada
Frontiers in Immunology (2024) Vol. 15
Open Access
